WEST PHARM.SVCS DL-,25/ US9553061055 /
| 06/11/2024 17:11:20 | Chg. +7.400 | Volume | Bid18:03:00 | Ask18:03:00 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 301.700EUR | +2.51% | - Turnover: - |
302.000Bid Size: 2,000 | 307.700Ask Size: 2,000 | 21.74 bill.EUR | - | - |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | - | 593.6000 | 669 | 711.7000 | 705.8000 | ||||||
| Intangible Assets | - | 52 | 50.6000 | 48.3000 | 42 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 1,011.6000 | ||||||
| Inventories | - | 151.8000 | 162.2000 | 176.9000 | 181.5000 | ||||||
| Accounts Receivable | - | 147.2000 | 175 | 185.7000 | 179 | ||||||
| Cash and Cash Equivalents | - | 91.8000 | 161.9000 | 230 | 255.3000 | ||||||
| Current Assets | - | 472 | 557.3000 | 650.7000 | 659.3000 | ||||||
| Total Assets | - | 1,399.1000 | 1,564 | 1,671.6000 | 1,670.9000 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | 89.8000 | 102.9000 | 108 | 103.1000 | ||||||
| Long-term debt | - | - | - | - | 309.5000 | ||||||
| Liabilities to Banks | - | 50.1000 | 32.7000 | 2.2000 | 27.2000 | ||||||
| Provisions | - | 31.1000 | 28.6000 | 26.7000 | 30.6000 | ||||||
| Liabilities | - | 744.2000 | 835.1000 | 765.2000 | 714 | ||||||
| Share Capital | - | 17.2000 | 17.2000 | 17.6000 | 17.8000 | ||||||
| Total Equity | - | 654.9000 | 728.9000 | 906.4000 | 956.9000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | - | 1,399.1000 | 1,564 | 1,671.6000 | 1,670.9000 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,104.7000 | 1,192.3000 | 1,266.4000 | 1,368.4000 | 1,368.4000 | ||||||
| Depreciation (total) | - | - | - | - | 81 | ||||||
| Operating Result | 90.7000 | 109.6000 | 135.1000 | 162.4000 | 162.4000 | ||||||
| Interest Income | -16.2000 | -16.9000 | -14.9000 | -15.1000 | 17 | ||||||
| Income Before Taxes | 74.5000 | 92.7000 | 108.6000 | 147.1000 | 147.1000 | ||||||
| Income Taxes | 13.6000 | 23.5000 | 32.7000 | 40.2000 | 40.2000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 65.3000 | 75.5000 | 80.7000 | 112.3000 | 112.3000 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 138.3000 | 130.7000 | 187.4000 | 220.5000 | 220.5000 | ||||||
| Cash Flow from Investing Activities | -74 | -120.5000 | -116 | -149.9000 | -149.9000 | ||||||
| Cash Flow from Financing | -34 | -24.7000 | -3.4000 | -5.1000 | -5.1000 | ||||||
| Decrease / Increase in Cash | 27.1000 | -18.4000 | 70.1000 | 68.1000 | 68.1000 | ||||||
| Employees | 6,408 | 6,300 | 6,700 | 6,900 | 7,000 | ||||||
